Filter Results:
(1,245)
Show Results For
- All HBS Web
(1,245)
- People (5)
- News (171)
- Research (928)
- Events (6)
- Multimedia (12)
- Faculty Publications (757)
Show Results For
- All HBS Web
(1,245)
- People (5)
- News (171)
- Research (928)
- Events (6)
- Multimedia (12)
- Faculty Publications (757)
- 01 Mar 2014
- News
My HBS Eureka Moment
uncomfortable with the ethnic background of the proponents, who were proposing to start a pharmaceutical company in Mexico. I could never get comfortable, and missed a huge opportunity. The product was the birth control pill." The lesson... View Details
- 01 Feb 2001
- News
Drilling Down
Exchange. "The role of intellectual capital is more important in this business than any other, except perhaps the pharmaceutical and computer science industries. Oil is a hugely volatile commodity that very few people want to play in, so... View Details
- 12 Jan 2016
- First Look
January 12, 2016
November–December 2015 Operations Research Active Postmarketing Drug Surveillance for Multiple Adverse Events By: Goh, Joel, Margrét V. Bjarnadóttir, Mohsen Bayati, and Stefanos A. Zenios Abstract—Postmarketing drug surveillance is the process of monitoring the adverse... View Details
Keywords: Carmen Nobel
- Web
Winners & Success Stories | New Venture Competition
Pharmaceuticals Alec Machiels, MBA 2001 Potentia is a clinical-stage biotechnology company with a world-class scientific team and scientific advisory board. The company’s mission is to bring the first treatment targeting the root cause of... View Details
- 26 Jul 2010
- Research & Ideas
Yes, You Can Raise Prices in a Downturn
have told the Wright brothers, "Don't do it: it's a bad use of capital!" Yet over the past two decades, Ryanair's ROE was often comparable to the best returns in the pharmaceutical business—a traditional example of a... View Details
- 05 May 2023
- News
Fail Better
Organization before being recruited to Boston-based Vertex Pharmaceuticals in 2017, where she was named CEO and president in 2020. Confessing her own discomfort with failure, Kewalramani reflects on an experience earlier in her career... View Details
- 02 Aug 2018
- News
Can Marketing Help Halt the Heroin Epidemic?
going to take care of themselves, meaning prescriber limits are coming down, the way that doctors are prescribing is changing, CDC have got guidelines, lawsuits against these pharmaceutical companies and the distributors. All those things... View Details
- March 2017
- Case
Cantel Medical
By: John R. Wells and Gabriel Ellsworth
Cantel Medical Corporation provided infection prevention and control products and services for patients, caregivers, and other healthcare providers. In 2016, Cantel generated sales of $665 million and net profits of $60 million, double the levels of five years earlier.... View Details
Keywords: Cantel; Charles Diker; Furniture Industry; Matrix Organization; Acquisition; Mergers and Acquisitions; Business Conglomerates; Business Units; Business Growth and Maturation; Business Organization; For-Profit Firms; Chemicals; Profit; Revenue; Geographic Scope; Multinational Firms and Management; Health; Health Care and Treatment; Business History; Business or Company Management; Goals and Objectives; Growth and Development Strategy; Organizational Structure; Problems and Challenges; Research and Development; Opportunities; Strategy; Adaptation; Business Strategy; Competitive Strategy; Corporate Strategy; Diversification; Expansion; Information Technology; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States; New Jersey
Wells, John R., and Gabriel Ellsworth. "Cantel Medical." Harvard Business School Case 717-482, March 2017.
- 04 Sep 2018
- First Look
New Research and Ideas, September 4, 2018
It subsequently became much more arduous for pharmaceutical firms to bring new drugs to market. Some critics therefore argued that the new regulations were actually detrimental, as they prevented or delayed good drugs from coming to... View Details
Keywords: Dina Gerdeman
- 24 Jan 2012
- First Look
First Look: Jan. 24
This chapter proposes a new lens to understand corruption, using internal records collected from firms that pay bribes. We examine widespread corruption in three industries in an Asian developing country: procurement, pharmaceutical... View Details
Keywords: Sean Silverthorne
- 24 Feb 2009
- First Look
First Look: February 24, 2009
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=909036 Esser & Ackermann at Mannesmann Harvard Business School Case 209-095 No abstract is available at this time. Purchase this case:... View Details
Keywords: Martha Lagace
- 21 May 2013
- First Look
First Look: May 21
pharmaceutical sales teams in Belgium and sports teams in Canada. These results suggest that a minor adjustment to employee bonuses-shifting the focus from the self to others-can produce measurable benefits for employees and... View Details
Keywords: Sean Silverthorne
- 19 Aug 2024
- News
Quantum Leap
Subscribe on iTunes Subscribe on Spotify More Skydeck episodes Dan Morrell: Hi, this is Dan Morrell, host of Skydeck. Quantum computing has long been talked about as one of the next big things—the kind of technology, like AI, that will change everything. But to our... View Details
- 20 Feb 2018
- First Look
First Look at New Research and Ideas, February 20, 2018
new fund. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/317036-PDF-ENG Harvard Business School Case 118-052 Charity or Bribery? Filip Kowalski, a senior manager at the pharmaceutical company Healthgen, leads sales for the... View Details
Keywords: Sean Silverthorne
- 03 Jan 2017
- First Look
January 3, 2017
silos within numerous academic medical centers, pharmaceutical companies, and some disease-based foundations. For new precision therapies to be developed, these data sets need to be shared broadly. Patients can help lead this effort by... View Details
Keywords: Carmen Nobel
- 18 Aug 2011
- Lessons from the Classroom
Business Plan Contest: 15 Years of Building Better Entrepreneurs
asking, is this the right business model? But there are no answers. The market and technology are constantly changing," Riesenfeld remarks. Important Sounding Board The biotech industry presents similar challenges in a space littered with failed companies. When... View Details
- 01 Jun 2011
- News
The Best-Laid Plans
failed companies. When Potentia Pharmaceuticals won the contest in 2001 with Alec Machiels (MBA 2001) at the helm, its plan hinged on a mechanism created by a team of Harvard and MIT scientists that used atomic force microscopy in drug... View Details
- 20 Jul 2022
- News
Wired to be Inspired
understand, first of all, don't get confused by purpose statements. Theranos had one. Purdue Pharmaceutical had one. Facebook pulled one out in 2016 when they were in trouble. And you read those statements and you’re like, you gotta be... View Details
- 24 May 2011
- First Look
First Look: May 24
case:http://cb.hbsp.harvard.edu/cb/product/211086-PDF-ENG Innovation and Growth at Actelion Ltd Gary P. Pisano, Daniela Beyersdorfer, and Ruth DittrichHarvard Business School Case 611-065 : In late 2010, Jean-Paul Clozel, CEO of the Swiss biotech View Details
Keywords: Sean Silverthorne
- 01 Apr 2000
- News
Getting the Message
Sponsorships allow advertisers to offer content that is related to their products or services and valued by the target audience. For example, a pharmaceutical company might sponsor a bulletin board for consumers with a specific ailment.... View Details
Keywords: Susan Young